Compounds > cp 115953
Page last updated: 2024-09-03

cp 115953 and levofloxacin

cp 115953 has been researched along with levofloxacin in 1 studies

Compound Research Comparison

Studies
(cp 115953)		Trials
(cp 115953)		Recent Studies (post-2010)
(cp 115953)		Studies
(levofloxacin)		Trials
(levofloxacin)		Recent Studies (post-2010) (levofloxacin)
20004,3465812,209

Protein Interaction Comparison

ProteinTaxonomycp 115953 (IC50)levofloxacin (IC50)
Replicase polyprotein 1abBetacoronavirus England 17.6

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Azéma, J; Dewelle, J; Guidetti, B; Kiss, R; Korolyov, A; Le Calve, B; Malet-Martino, M; Martino, R; Mijatovic, T; Vaysse, J1

Other Studies

1 other study(ies) available for cp 115953 and levofloxacin

ArticleYear
7-((4-Substituted)piperazin-1-yl) derivatives of ciprofloxacin: synthesis and in vitro biological evaluation as potential antitumor agents.
    Bioorganic & medicinal chemistry, 2009, Aug-01, Volume: 17, Issue:15

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Ciprofloxacin; Humans; Maximum Tolerated Dose; Mice; Neoplasms; Piperazine; Piperazines

2009